Clinical Trials Browser

Withdrawn × Advanced Endometrial Cancer × pembrolizumab × Clear all

NCT06046274 2024-04-30

GEN1046 in Combination With Anticancer Agents for the Treatment of Advanced Endometrial Cancer

Phase 2 Withdrawn

Advanced Endometrial Cancer